Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?
Several years ago I bought shares of 3M (NYSE: MMM) even though it was in the middle of a major class-action lawsuit. I believed the industrial giant would survive the legal issues, which it has. But I was surprised at how difficult it was for me to stick it out, given the lack of information from the company on the legal front.I think Johnson & Johnson (NYSE: JNJ) is a great company, but I see visions of 3M when I look at it -- which is why I opted for the high-yield stock of a competitor. Here's why you also might want to skip J&J and buy Medtronic (NYSE: MDT) instead.After spinning off its consumer-products operations, Johnson & Johnson was left with two main business lines: pharmaceuticals and medical devices. Healthcare is incredibly complex, and I don't pretend to understand everything that the company does, but it is an industry leader in both areas. And it has a proven track record of success in a somewhat tangential area.Continue reading
Several years ago I bought shares of 3M (NYSE: MMM) even though it was in the middle of a major class-action lawsuit. I believed the industrial giant would survive the legal issues, which it has. But I was surprised at how difficult it was for me to stick it out, given the lack of information from the company on the legal front.
I think Johnson & Johnson (NYSE: JNJ) is a great company, but I see visions of 3M when I look at it -- which is why I opted for the high-yield stock of a competitor. Here's why you also might want to skip J&J and buy Medtronic (NYSE: MDT) instead.
After spinning off its consumer-products operations, Johnson & Johnson was left with two main business lines: pharmaceuticals and medical devices. Healthcare is incredibly complex, and I don't pretend to understand everything that the company does, but it is an industry leader in both areas. And it has a proven track record of success in a somewhat tangential area.
